Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Axonics, Inc. AXNX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$71.00
+0%

Axonics, Inc. (AXNX) is a Medical - Devices company in the Healthcare sector, currently trading at $70.98. It has a SharesGrow Score of 52/100, indicating a mixed investment profile with 3 out of 7 criteria passed.

Analyst consensus target is AXNX = $71 (+0% upside).

Financials: revenue is $366M, +49.1%/yr average growth. Net income is $6M (loss), growing at +23.1%/yr. Net profit margin is -1.7% (negative). Gross margin is 74.9% (+14.7 pp trend).

Balance sheet: total debt is $28M against $638M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 10.73 (strong liquidity). Debt-to-assets is 3.8%. Total assets: $720M.

Analyst outlook: 7 / 15 analysts rate AXNX as buy (47%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 50/100 (Partial), Growth 100/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 70/100 (Pass), Future 34/100 (Fail), Income 10/100 (Fail).

$71.00
▲ 0.03% Upside
Average Price Target
The 12-month price target for Axonics, Inc. is $71.00.

AXNX SharesGrow Score Overview

61/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 50/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 70/100
Gross margin is + market cap
FUTURE 34/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AXNX

~
VALUE Partial
50/100
AXNX trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $71, implying +0% from the current price $71. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
100/100
AXNX: +49.1%/yr revenue is, +23.1%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet AXNX: Debt-to-Equity (D/E) ratio 0.04 (conservative), Current ratio is 10.73 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
70/100
AXNX: Gross margin is 74.9% (+14.7 pp trend), $4B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 70/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
34/100
Analyst outlook: 7 / 15 analysts rate AXNX as buy (47%). Analyst consensus target is $71 (+0% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
AXNX: Net profit margin is -1.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
Market Cap$3.63B
Beta (1Y)0.83
Share Statistics
EPS (TTM)-0.12
Shares Outstanding$49.08M
IPO Date2018-10-31
Employees797
CEORaymond W. Cohen
Financial Highlights & Ratios
Revenue (TTM)$366.38M
Gross Profit$274.55M
EBITDA$7.78M
Net Income$-6.09M
Operating Income$-26.06M
Total Cash$344.96M
Total Debt$27.62M
Net Debt$-77.19M
Total Assets$719.92M
Price / Earnings (P/E)-591.5
Price / Sales (P/S)9.9
Analyst Forecast
1Y Price Target$71.00
Target High$71.00
Target Low$71.00
Upside+0.0%
Rating ConsensusHold
Analysts Covering15
Buy 47% Hold 53% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS05465P1012

Price Chart

Track all markets on TradingView
AXNX
Axonics, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices

People Also View

MDT
MDT
Medtronic plc
$88.12
+0.14%
 GKOS
GKOS
Glaukos Corporation
$120.52
+0.86%
 BRKR
BRKR
Bruker Corporation
$39.90
+2.18%
 IRTC
IRTC
iRhythm Technologies, Inc.
$123.23
+2.31%
 LIVN
LIVN
LivaNova PLC
$64.99
+0.63%
 ITGR
ITGR
Integer Holdings Corporation
$88.63
+1.03%
 NUVA
NUVA
NuVasive, Inc.
$39.75
-2.24%
 HSKA
HSKA
Heska Corporation
$119.99
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message